[go: up one dir, main page]

NO20023425D0 - Fremgangsmåte for lindring av angst - Google Patents

Fremgangsmåte for lindring av angst

Info

Publication number
NO20023425D0
NO20023425D0 NO20023425A NO20023425A NO20023425D0 NO 20023425 D0 NO20023425 D0 NO 20023425D0 NO 20023425 A NO20023425 A NO 20023425A NO 20023425 A NO20023425 A NO 20023425A NO 20023425 D0 NO20023425 D0 NO 20023425D0
Authority
NO
Norway
Prior art keywords
procedures
relieving anxiety
anxiety
relieving
Prior art date
Application number
NO20023425A
Other languages
English (en)
Other versions
NO20023425L (no
Inventor
Robert F Mayol
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27047894&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20023425(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20023425D0 publication Critical patent/NO20023425D0/no
Publication of NO20023425L publication Critical patent/NO20023425L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20023425A 2000-01-18 2002-07-17 Fremgangsmåte for lindring av angst NO20023425L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48416100A 2000-01-18 2000-01-18
US09/588,221 US6150365A (en) 1999-08-05 2000-06-06 Anxiety method
PCT/US2000/028800 WO2001052853A1 (en) 2000-01-18 2000-10-18 Anxiety method

Publications (2)

Publication Number Publication Date
NO20023425D0 true NO20023425D0 (no) 2002-07-17
NO20023425L NO20023425L (no) 2002-09-05

Family

ID=27047894

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023425A NO20023425L (no) 2000-01-18 2002-07-17 Fremgangsmåte for lindring av angst

Country Status (22)

Country Link
US (1) US6150365A (no)
EP (1) EP1248622B1 (no)
JP (1) JP2003520236A (no)
KR (1) KR20020073176A (no)
CN (1) CN1424911A (no)
AR (1) AR028201A1 (no)
AT (1) ATE300302T1 (no)
AU (1) AU775591B2 (no)
BR (1) BR0016971A (no)
CA (1) CA2406732A1 (no)
CZ (1) CZ20022461A3 (no)
DE (1) DE60021609D1 (no)
HU (1) HUP0204285A3 (no)
IL (1) IL150019A0 (no)
MX (1) MXPA02007003A (no)
NO (1) NO20023425L (no)
NZ (1) NZ520823A (no)
PL (1) PL355966A1 (no)
RU (1) RU2254132C2 (no)
TW (1) TWI226831B (no)
UY (1) UY26440A1 (no)
WO (1) WO2001052853A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050137206A1 (en) * 1999-08-05 2005-06-23 Yevich Joseph P. Method for treatment of anxiety and depression
US20030069251A1 (en) * 1999-08-05 2003-04-10 Yevich Joseph P. Antianxiety composition
US6150365A (en) * 1999-08-05 2000-11-21 Bristol-Myers Squibb Company Anxiety method
WO2002077168A2 (en) * 2001-03-22 2002-10-03 Merck & Co., Inc. Mch1r deficient mice
US6593331B2 (en) 2001-04-17 2003-07-15 Laboratories Upsa Method for treatment of pain
US6821976B2 (en) * 2001-07-24 2004-11-23 Bristol-Myers Squibb Company S-6-hydroxy-buspirone
US6686361B2 (en) 2001-07-24 2004-02-03 Bristol-Myers Squibb Company R-6-hydroxy-buspirone
JP2005535708A (ja) * 2002-08-12 2005-11-24 ブリストル−マイヤーズ　スクイブ　カンパニー ヒドロキシアザピロンの改良合成法
US20040147581A1 (en) * 2002-11-18 2004-07-29 Pharmacia Corporation Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy
JP2006515326A (ja) * 2003-01-30 2006-05-25 ダイノジェン ファーマシューティカルズ， インコーポレイテッド 胃腸管障害を処置するためのナトリウムチャネルモジュレーターの使用
CN101273046B (zh) * 2005-09-28 2011-05-25 弗·哈夫曼-拉罗切有限公司 作为加压素受体拮抗剂的吲哚-3-基-羰基氮杂螺环衍生物
PL2627328T3 (pl) 2010-10-15 2017-03-31 Contera Pharma Aps Połączenia agonistów receptorów serotoninowych do stosowania w leczeniu zaburzeń ruchowych
WO2013156035A1 (en) 2012-04-18 2013-10-24 Concit Pharma Aps Orally available pharmaceutical formulation suitable for improved management of movement disorders
DK3160464T3 (en) * 2014-06-26 2018-10-29 Contera Pharma Aps 6-hydroxybuspirone for use in the treatment of movement disorders
CN109689036A (zh) 2016-07-11 2019-04-26 康特拉医药公司 用于治疗早晨运动不能的脉冲药物输送系统

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
US4409223A (en) * 1982-08-06 1983-10-11 Riblet Leslie A Anxiolytic method
US5633009A (en) * 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones
US5431922A (en) * 1991-03-05 1995-07-11 Bristol-Myers Squibb Company Method for administration of buspirone
ZA954689B (en) * 1994-06-08 1996-01-29 Lundbeck & Co As H 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines
AU5101798A (en) * 1996-12-04 1998-06-29 Bristol-Myers Squibb Company Method for oral administration of buspirone
US6150365A (en) * 1999-08-05 2000-11-21 Bristol-Myers Squibb Company Anxiety method

Also Published As

Publication number Publication date
EP1248622A1 (en) 2002-10-16
BR0016971A (pt) 2002-10-15
NO20023425L (no) 2002-09-05
EP1248622B1 (en) 2005-07-27
PL355966A1 (en) 2004-05-31
WO2001052853A1 (en) 2001-07-26
AU1213001A (en) 2001-07-31
AR028201A1 (es) 2003-04-30
HUP0204285A3 (en) 2004-07-28
US6150365A (en) 2000-11-21
TWI226831B (en) 2005-01-21
IL150019A0 (en) 2002-12-01
ATE300302T1 (de) 2005-08-15
DE60021609D1 (de) 2005-09-01
KR20020073176A (ko) 2002-09-19
UY26440A1 (es) 2001-08-27
CZ20022461A3 (cs) 2003-09-17
JP2003520236A (ja) 2003-07-02
HUP0204285A2 (en) 2003-05-28
CA2406732A1 (en) 2001-07-26
MXPA02007003A (es) 2003-01-28
RU2002118304A (ru) 2004-01-10
NZ520823A (en) 2004-05-28
RU2254132C2 (ru) 2005-06-20
EP1248622A4 (en) 2004-02-04
AU775591B2 (en) 2004-08-05
CN1424911A (zh) 2003-06-18

Similar Documents

Publication Publication Date Title
DE60135078D1 (de) Hochfrequenzvorrichtung
DE60123990D1 (de) Medizinische greifvorrichtung
NO20025580D0 (no) Medisinsk anordning
DE60105874D1 (de) Ophthalmisches Gerät
DE60123496D1 (de) Verbindungsherstellungsvorrichtung
DE50013364D1 (de) Filtervorrichtung
NO20023425D0 (no) Fremgangsmåte for lindring av angst
DE60120082D1 (de) Spinnvorrichtung
DE60122836D1 (de) Ophthalmische Linse-Erzeugungsvorrichtung
DE60126075D1 (de) Auftragsvorrichtung
DE60127017D1 (de) Aufschlämmungsrückfluss-Vorrichtung
DE60109663D1 (de) Ophthalmische Einrichtung
NO20005524L (no) Ror-i-roranordning
DE60142401D1 (de) Verbindungsverfahren
DE10194843T1 (de) Anschlusseinrichtung
NO20032156D0 (no) Behandling av angstforstyrrelser
DK1257278T3 (da) Anvendelse af mirtazapin til behandling af sövnforstyrrelser
DE60005566D1 (de) Pyranoindole zur glaukombehandlung
DE60119061D1 (de) Justierbare Begrenzungsvorrichtung
DE60102024D1 (de) Verbindungsvorrichtung
NO20031092D0 (no) Fremgangsmåte for fjerning av urenheter
DE60125959D1 (de) Unterscheidung zwischen gnrh-i und gnrh-ii
EP1283262A4 (en) Neurotrophic factor expression-inducing agent
DE50108156D1 (de) Filtereinrichtung
NO20002993D0 (no) FremgangsmÕte for bonuspoenganvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application